Companies

Autolus Therapeutics plc (AUTL) SEC filings

CIK 0001730463 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in X0 · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)75.4 M
Net income (USD)-287.5 M-208.4 M-148.8 M
Diluted EPS (USD/shares)-1.08-1.2-1.57

Latest filings

FiledFormDescriptionPeriod
2026-09-22EFFECTEFFECT items ,,
2026-09-22424B3424B3
2026-09-15DEL AMDEL AM
2026-09-14S-3S-3
2026-09-034PRIMARY DOCUMENT2026-09-01
2026-09-02144144
2026-08-28SCHEDULE 13D/ASCHEDULE 13D/A
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-1110-Q10-Q2026-06-30
2026-08-118-K8-K items 2.02,7.01,9.012026-08-11
2026-08-038-K8-K items 7.01,8.01,9.012026-08-03
2026-08-038-K8-K items 1.01,2.03,3.02,9.012026-07-30
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-07-014PRIMARY DOCUMENT2026-06-29
2026-06-298-K8-K items 5.072026-06-29
2026-06-098-K8-K items 8.012026-06-05
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 6-K 51, 8-K 46, SC 13G/A 25, 3 21, CORRESP 17, UPLOAD 17, SC 13G 15, SC 13D/A 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=AUTL (0.002 USD), /gw/filings/filings?ticker=AUTL&form=8-K, /gw/filings/facts?ticker=AUTL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange